Zobrazeno 1 - 10
of 207
pro vyhledávání: '"Cerny MA"'
Autor:
Savaryn JP; AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA. john.savaryn@abbvie.com., Coe K; J&J, Translational PKPD & Investigational Toxicology, San Diego, CA, USA., Cerny MA; Pfizer, Inc, Groton, CT, USA., Colizza K; GSK, DMPK Disposition and Biotransformation, Collegeville, PA, USA. kevin.x.colizza@gsk.com., Moliner P; Sanofi, Montpellier, France., King L; UCB Biopharma, Dept. of DMPK, Slough, UK., Ma B; Genentech, Inc., Department of Drug Metabolism and Pharmacokinetics, South San Francisco, CA, USA., Atherton J; Incyte Research Institute, Translational Sciences, Wilmington, DE, USA., Auclair A; Boehringer Ingelheim Pharmaceuticals, Inc.,Drug Metabolism and Pharmacokinetics, Ridgefield, CT, USA., Cancilla MT; Merck & Co., Inc., Pharmacokinetics, Dynamics, Metabolism, and Bioanalysis, Rahway, NJ, USA., Eno M; Eisai Inc., Global Drug Metabolism and Pharmacokinetics, Cambridge, MA, USA., Jurva U; AstraZeneca, Drug Metabolism and Pharmacokinetics (DMPK), Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, Gothenburg, Sweden., Yue Q; Gilead Sciences, Inc., Drug Metabolism Dept, Foster City, CA, USA., Zhu SX; Takeda Development Center Americas, Inc., Drug Metabolism and Pharmacokinetics & Modeling, Cambridge, MA, USA., Freiberger E; AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA., Zhong G; Amgen, Pharmacokinetics and Drug Metabolism Department, South San Francisco, CA, USA., Barlock B; Blueprint Medicines, Cambridge, MA, USA., Nachtigall J; Merck Healthcare KGaA, Department NCE DMPK, Darmstadt, Germany., Laboureur L; R&D Paris-Saclay Servier Institute, DMPK, Gif-Sur-Yvette, France., Pusalkar S; Servier Bioinnovation, LLC, DMPK, Boston, MA, USA., Guo R; Beigene, DMPK, Department of Biology, Shanghai, China., Niehues M; Bayer AG, In Vitro ADME & Isotope Chemistry, Berlin, Germany., Hauri S; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Carreras ET; Novartis Pharma AG, Novartis Institute for Biomedical Research, Basel, Switzerland., Maurer C; Merck Healthcare KGaA, Department NCE DMPK, Darmstadt, Germany., Prakash C; DMPK/Clinical Pharmacology, Agios Pharmaceuticals, Cambridge, MA, USA., Jenkins GJ; AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.
Autor:
Filipski KJ; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Martinez-Alsina LA; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Reese MR; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Evrard E; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Buzon LM; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Cameron KO; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Zhang Y; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Coffman KJ; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Bradow J; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Kormos BL; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Liu S; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Knafels JD; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Sahasrabudhe PV; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Chen J; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Kalgutkar AS; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Bessire AJ; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Orozco CC; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Balesano A; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Cerny MA; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Bollinger E; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Reyes AR; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Laforest B; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Rosado A; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Williams G; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Marshall M; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Tam Neale K; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Chen X; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Hirenallur-Shanthappa D; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Stansfield JC; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Groarke J; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Qiu R; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Karas S; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Roth Flach RJ; Pfizer Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Esler WP; Pfizer Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.
Autor:
Bauman JN; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.) jonathan.bauman@pfizer.com., Doran AC; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Gualtieri GM; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Hee B; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Strelevitz T; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Cerny MA; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Banfield C; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Plotka A; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Wang X; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Purohit VS; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Dowty ME; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Sep 16; Vol. 52 (10), pp. 1124-1136. Date of Electronic Publication: 2024 Sep 16.
Autor:
Rodrigues D; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Niosi M; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Eng H; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Healy C; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Lazzaro S; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA., Yang Q; Computational Chemistry, Internal Medicine, Medicine Design, Worldwide Research & Development, Cambridge, Massachusetts, USA., Cerny MA; Pharmacokinetics & Drug Metabolism, Medicine Design, Worldwide Research & Development, Pfizer Inc., Groton, Connecticut, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2023 Aug; Vol. 63 (8), pp. 875-879. Date of Electronic Publication: 2023 Apr 27.
Autor:
Orozco CC; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Neuvonen M; Department of Clinical Pharmacology, University of Helsinki, Helsinki FI-00014, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki FI-00014, Finland., Bi YA; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Cerny MA; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Mathialagan S; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Tylaska L; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Rago B; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Costales C; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., King-Ahmad A; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States., Niemi M; Department of Clinical Pharmacology, University of Helsinki, Helsinki FI-00014, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki FI-00014, Finland.; Department of Clinical Pharmacology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki FI-00029, Finland., Rodrigues AD; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2023 Jun 05; Vol. 20 (6), pp. 3020-3032. Date of Electronic Publication: 2023 May 03.
Autor:
Cerny MA; Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, Connecticut matthew.cerny@pfizer.com., Spracklin DK; Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, Connecticut., Obach RS; Pharmacokinetics, Dynamics, and Metabolism, Pfizer, Inc., Groton, Connecticut.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2023 Jun; Vol. 51 (6), pp. 647-656. Date of Electronic Publication: 2023 Mar 27.
Autor:
Russell DA; Department of Medicinal Chemistry, University of Washington, Seattle, WA, United States., Cerny MA; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Groton, CT, United States. Electronic address: matthew.cerny@pfizer.com.
Publikováno v:
Methods in enzymology [Methods Enzymol] 2023; Vol. 690, pp. 341-368. Date of Electronic Publication: 2023 Sep 09.
Autor:
Weng Y; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., United States., Fonseca KR; PDM, Pfizer Inc, United States., Bi YA; Pfizer Inc., United States., Mathialagan S; Pharmacokinetics, Pharmacodynamics, and Metabolism, Medicine Design, Pfizer Inc, United States., Riccardi K; Pfizer, United States., Tseng E; Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global Research and Development, United States., Bessire AJ; Pfizer, United States., Cerny MA; PDM, Pfizer Global Research and Development, United States., Tess DA; Medicine Design, Pfizer Inc., United States., Rodrigues AD; Drug Metabolism and Pharmacokinetics, Pfizer, United States., Kalgutkar AS; Medicine Design, Pfizer Worldwide Research and Development, United States., Litchfield JE; PDM, Pfizer, United States., Di L; Pharmacokintics Dynamics and Metabolism, Pfizer Inc., United States., Varma MVS; Pharmacokinetics Dynamics and Metabolism, Pfizer Inc, United States manthena.v.varma@pfizer.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2022 Jul 02. Date of Electronic Publication: 2022 Jul 02.
Autor:
Tseng E; Medicine Design, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut elaine.tseng@pfizer.com r.scott.obach@pfizer.com., Eng H; Medicine Design, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut., Lin J; Medicine Design, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut., Cerny MA; Medicine Design, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut., Tess DA; Medicine Design, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut., Goosen TC; Medicine Design, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut., Obach RS; Medicine Design, Worldwide Research and Development, Pfizer Inc., Groton, Connecticut elaine.tseng@pfizer.com r.scott.obach@pfizer.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2021 Oct; Vol. 49 (10), pp. 947-960. Date of Electronic Publication: 2021 Jul 29.
Autor:
Neuvonen M; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland., Hirvensalo P; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland., Tornio A; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland., Rago B; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., West M; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., Lazzaro S; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., Mathialagan S; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., Varma M; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., Cerny MA; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., Costales C; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., Ramanathan R; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., Rodrigues AD; ADME Sciences, Medicine Design, Pfizer Inc., Groton, Connecticut, USA., Niemi M; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Mar; Vol. 109 (3), pp. 646-657. Date of Electronic Publication: 2020 Oct 18.